T-cell and monocyte subsets, inflammatory molecules, rejection, and hemodynamics early after cardiac transplantation

Transplantation

Volumn 65, Issue 9, 1998, Pages 1255-1261

  Deng, Mario C ^a,b   Erren, Michael ^a   Roeder, Norbert ^a   Dreimann, Volker ^a   Günther, Franziska ^a   Kerber, Sebastian ^a   Baba, Hideo A ^a   Schmidt, Christoph ^a   Breithardt, Günter ^a   Scheld, Hans H ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LUNG CAPILLARY PRESSURE; LUNG VASCULAR RESISTANCE; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MALE; MEAN ARTERIAL PRESSURE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; CYTOKINES; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HUMANS; IMMUNE SYSTEM; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MONOCYTES; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 0032525062     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199805150-00018     Document Type: Article

References (42)

1. Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report (1996). J Heart Lung Transplant 1996; 15: 655.
2. Salgame P, Abrams JS, Clayberger C, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254: 279.
3. Valantine HA. Invited editorial: rejection surveillance by Doppler echocardiography. J Heart Lung Transplant 1993; 12: 422.
4. Valantine HA, Johnson F, Dong C, et al. Cytokines as potential mediators of acute allograft diastolic dysfunction: a pilot study using in-situ-hybridization [Abstract]. J Heart Lung Transplant 1994; 13: S32.
5. Fyfe A, Daly P, Galligan L, Pire L, Feindel C, Cardella C. Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and interleukin-4-production within the graft. J Am Coll Cardiol 1993; 21: 171.
6. Kimball PM, Radovancevic B, Isom T, Spickard A, Frazier OH. The paradox of cytokine monitoring: predictor of immunologic activity as well as immunologic silence following cardiac transplantation. Transplantation 1996; 61: 909.
7. Grant SCD, Guy SP, Lamb WR, Brooks NH, Brenchley PEC, Hutchinson FV. Expression of cytokine messenger RNA after heart transplantation: relationship with rejection and serum cytokines. Transplantation 1996; 62: 910.
8. Grant SCD, Lamb WR, Yonan N, Hutchinson IV, Brenchley PEC. Antithymocyte globulin preparations after heart transplantation. Transplantation 1995; 60: 684.
9. Deng MC, Kämmerling L, Erren M, et al. Relation of interleukin (IL)-6, tumor-necrosis factor-α, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction and mortality early after cardiac transplantation. Transplantation 1995; 60: 1118.
10. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffinan RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348.
11. Billingham ME, Cary N, Hammond E, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung transplant rejection: Heart Rejection Study Group. J Heart Transplant 1990; 9: 587.
12. Park JW, Warnecke H, Deng M, Schüler S, Heinrich KW, Hetzer R. Early diastolic left ventricular function as a marker of acute cardiac rejection: a prospective serial echocardiographic study. Int J Cardiol 1992; 37: 351.
13. Valantine HA, Fowler MB, Hunt SA, et al. Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. Circulation 1987; 76 (suppl V): V86.
14. Deng MC, Erren M, Dreimann V, Rotering H, Breithardt G, Scheld HH. Serial multiparametric immune monitoring as a guide to management early after cardiac transplantation. In: Faist E, ed. Fourth International Congress on the Immune Consequences of Trauma, Shock and Sepsis. Bologna, Italy: Monduzzi, 1997: 187.
15. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation [review article]. N Engl J Med 1995; 332: 1351.
16. Nathan C, Sporn M. Cytokines in context. J Cell Biol 1991; 113: 981.
17. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387.
18. Suffredini AF, Fromm RE, Parker MM, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321: 280.
19. Hocking DC, Phillips PG, Ferro TJ, Johnson A. Mechanisms of pulmonary edema induced by tumor necrosis factor-α. Circ Res 1990; 67: 68.
20. Oddis CV, Simmons RL, Hattler BG, Finkel MS. Chronotropic effects of cytokines and the nitric oxide synthase inhibitor, L-NMMA, on cardiac myocytes. Biochem Biophys Res Commun 1994; 205: 992.
21. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 1989; 86: 6753.
22. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 1994; 105: 897.
23. Parrillo JE. Pathogenetic mechanisms in septic shock. N Engl J Med 1993; 328: 1471.
24. Maury CPJ, Teppo AM. Circulating tumour necrosis factor-α (cachectin) in myocardial infarction. J Intern Med 1989; 225: 333.
25. Rosenberg SA, Lotze MT, Muul LM, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889.
26. Deyton L, Walker R, Kovacs J, et al. Reversible cardiac dysfunction associated with interferon-alfa therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med 1989; 321: 1246.
27. Westaby S. Organ dysfunction after cardiopulmonary bypass: a systemic inflammatory reaction induced by the extracorporeal circuit. Int Care Med 1987; 13: 89.
28. Deng MC, Wiedner M, Erren M, Möllhoff T, Assmann G, Scheld HH. Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 1995; 9: 22.
29. Deng MC, Dasch B, Erren M, et al. Impact of left ventricular dysfunction on cytokines, hemodynamics and outcome in bypass surgery. Ann Thorac Surg 1996; 62: 184.
30. Jordan SC, Czer L, Toyoda M, et al. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy. J Heart Lung Transplant 1993; 12: 333.
31. Grant SCD, Lamb WR, Brooks NH, Brenchley PEC, Hutchinson IV. Serum cytokines in human heart transplant recipients. Transplantation 1996; 62: 480.
32. Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996; 93: 720.
33. DeMaria R, Zuccelli GC, Masini S, et al. Nonspecific increase of interleukin-2 receptor serum levels during immune events in heart transplantation. Transplant Proc 1989; 21: 440.
34. Halloran PF, Cockfield SM, Mandrenas J. The mediators of inflammation (interleukin-1, interferon gamma, and TNF-α) and their relevance to rejection. Transplant Proc 1989; 21: 26.
35. Lange LG, Schreiner GF. Immune mechanisms of cardiac disease. N Engl J Med 1994; 330: 1129.
36. Marty C, Misset B, Tamion F, Fitting C, Carlet J, Cavaillon JM. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994; 22: 673.
37. Moscovitz H, Shofer F, Mignott H, Behrmann A, Kilpatrick L. Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity. Crit Care Med 1994; 22: 1102.
38. Young JB, Windsor NT, Smart FW, et al. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation. Transplantation 1991; 51: 636.
39. Lagoo AS, George JF, Naftel DC, et al. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients. J Heart Lung Transplant 1996; 15: 206.
40. Normann SJ, Peck AB, Staples ED, Salomon DR, Mills RM Jr. Experimental and clinical allogeneic heart transplant rejection: correlations between histology and immune reactivity detected by cytokine messenger RNA. J Heart Lung Transplant 1996; 15: 778.
41. Döcke WD, Reinke P, Staffa G, et al. An immune monitoring program for the management of immunosuppressive therapy in the early phase after transplantation. Transplant Med 1994; 6: 13.
42. Doecke WD, Reinke P, Syrbe U, et al. Immunoparalysis in sepsis: from phenomenon to treatment strategies. Transplant Med 1997; 9: 55.